Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ISB 2302
- Development stage
- Preclinical
- Lead developer
- IGI Therapeutics
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
ISB 2302 is a preclinical-stage bispecific immune modulator being developed by Glenmark Specialty, through its innovation-focused subsidiary Ichnos Sciences, for the treatment of hematologic and solid tumors. The molecule is engineered using the proprietary BEAT® (Bispecific Engagement by Antibodies based on the T-cell receptor) platform, which allows for the design of multispecific antibodies that maintain the structural and pharmacokinetic properties of conventional IgG antibodies. While the specific molecular targets of ISB 2302 have not been publicly disclosed, the asset is part of a pipeline of next-generation biologics intended to overcome tumor resistance and enhance anti-cancer immune responses.
- Other names
- ISB 2302ISB2302ISB-2302
Beyond the preview
Go deeper on ISB 2302.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ISB 2302.